Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Ryan Specialty Holdings, Inc. RYAN | T. Rowe Price Investment Management Inc. | 7,552,002 5.900% | 7,552,002 (New Position) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Sportradar Group AG SRAD | T. Rowe Price Investment Management Inc. | 12,080,674 5.500% | 12,080,674 (New Position) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | Amplitude, Inc. AMPL | T. Rowe Price Investment Management Inc. | 441 0.000% | -5,071,393 (-99.99%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | T. Rowe Price Investment Management Inc. | 3,236,595 5.900% | 3,236,595 (New Position) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | Ponce Financial Group, Inc. PDLB | T. Rowe Price Investment Management Inc. | 1,896,773 7.900% | -259,728 (-12.04%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Arcellx, Inc. ACLX | T. Rowe Price Investment Management Inc. | 10,560,425 18.300% | 955,791 (+9.95%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Netskope, Inc. Class A Common Stock NTSK | T. Rowe Price Investment Management Inc. | 3,556,583 4.200% | 456,321 (+14.72%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Curbline Properties Corp. CURB | T. Rowe Price Investment Management Inc. | 13,342,821 12.700% | 2,711,801 (+25.51%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | MapLight Therapeutics, Inc. MPLT | T. Rowe Price Investment Management Inc. | 7,726,298 6.200% | 7,726,298 (New Position) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | Aebi?Schmidt Holding?AG AEBI | T. Rowe Price Investment Management Inc. | 3,811,256 4.900% | -148,763 (-3.76%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Commercial Bancgroup, Inc. Common Stock CBK | T. Rowe Price Investment Management Inc. | 793,045 6.500% | 793,045 (New Position) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | Pebblebrook Hotel Trust PEB | T. Rowe Price Investment Management Inc. | 7,303,706 6.400% | -2,919,592 (-28.56%) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | TechnipFMC plc FTI | T. Rowe Price Investment Management Inc. | 23,232,013 5.700% | -5,843,807 (-20.10%) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | Warrior Met Coal, Inc. HCC | T. Rowe Price Investment Management Inc. | 2,064,481 3.900% | -609,391 (-22.79%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | CenterPoint Energy, Inc. CNP | T. Rowe Price Investment Management Inc. | 58,286,690 8.900% | 13,554,985 (+30.30%) | Filing History |
| 2026-02-17 10:28 am Purchase | 2025-12-31 | 13G | Pool Corporation POOL | T. Rowe Price Investment Management Inc. | 2,001,987 5.400% | 2,001,987 (New Position) | Filing History |
| 2026-02-06 10:08 am Purchase | 2026-01-31 | 13G | Endava plc DAVA | T. Rowe Price Investment Management Inc. | 4,078,281 10.000% | 191,803 (+4.94%) | Filing History |
| 2026-02-06 10:08 am Purchase | 2026-01-31 | 13G | Shattuck Labs, Inc. STTK | T. Rowe Price Investment Management Inc. | 7,373,891 11.700% | 7,373,891 (New Position) | Filing History |
| 2026-02-06 09:54 am Purchase | 2025-12-31 | 13G | Endava plc DAVA | T. Rowe Price Investment Management Inc. | 3,886,478 9.500% | 1,707,657 (+78.38%) | Filing History |
| 2026-01-08 12:15 pm Purchase | 2025-12-31 | 13G | BioLife Solutions, Inc. BLFS | T. Rowe Price Investment Management Inc. | 5,180,824 10.800% | 934,118 (+22.00%) | Filing History |